Although the risk is relatively rare, the number of people at risk is high because of the number of people who take GLP-1 drugs containing semaglutide
Adults over 45 often choose NMN for NAD+ support, cellular energy routines, and healthy-aging support
What were witnessing with Lp(a) is not just a lipid storyits a cardiovascular outcomes story unfolding at a pivotal moment for our industry
TRIUMPH-4: knee osteoarthritis (completed) TRIUMPH-4 is the first and, as of April 2026, the only Phase 3 trial to report results
Your healthcare provider will work closely with you to monitor your progress and make any necessary adjustments to ensure optimal results
Originally developed for type 2 diabetes (DM2), SMG has shown significant efficacy in weight reduction, with superior results compared to other treatments in the same class